Drugs used to manage connective tissue disease (CTD) associated with interstitial lung disease (ILD) (CTD-ILD) include nintedanib, corticosteroids, and antineoplastic agents. (medscape.com)
Healthcare worker s are increasingly being exposed to antineoplastic and other hazardous drugs. (cdc.gov)
Several factors have contributed to the potential for increase in exposure of healthcare worker s to antineoplastic and other hazardous drugs. (cdc.gov)
These include increasing numbers of patients with cancer and other chronic illnesses, the use of higher doses of drugs (made possible by strategies to reduce the toxic side-effects of the drugs), noncancer use of antineoplastic drugs and the development of other potent drugs, such as antiviral agents. (cdc.gov)
Because it has been well documented over the past 20 years that healthcare worker s, especially pharmacists and nurses , are exposed to these drugs in the workplace, government institutions and professional organisations around the world have developed guidelines for the safe handling of antineoplastic and other hazardous drugs. (cdc.gov)
In the USA, the National Institute for Occupational Safety and Health (NIOSH)l recently published an alert that lists recommendations for the safe handling of all hazardous drugs, of which antineoplastic drugs are the major class. (cdc.gov)
Others classes of hazardous drugs include some hormonal, immunosuppressive and antiviral agents, monoclonal antibodies and several miscellaneous drugs. (cdc.gov)
Here the transgenic strain FVB/N-Tg(MMTV-PyVT)634Mul/J (also known as PyVT) was used as a model system for measuring tumor burden and drug sensitivity of the antineoplastic drugs tamoxifen, cisplatin, and paclitaxel on tumorigenesis at an early stage of mammary carcinoma development in a male mouse model. (elsevierpure.com)
Therapeutic2
acetoxy-17-(3-pyridyl) androsta-5, 16-diene), in combination with at least one additional therapeutic agent such as an anti¬ cancer agent or a steroid. (gc.ca)
hydroxylase/C17, 20-lyase inhibitor, and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid. (gc.ca)
Tamoxifen1
Patients who received any prior hormonal anti-cancer therapy for advanced breast cancer, except for = 14 days of tamoxifen or NSAI ± goserelin for advanced breast cancer prior to randomization. (who.int)
Chemotherapy3
OBJECTIVES: To estimate the resource utilization and costs related to endocrine therapy (ET) versus chemotherapy (CT) in the treatment of hormonal receptor positive (HR+), advanced breast cancer (ABC) patients, after at least one previous ET. (usp.br)
Chemotherapy is a common treatment for cancer, involving the use of antineoplastic agents to destroy tumor cells by interfering with their cellular functions, including replication. (qdnurses.com)
Systemic treatment for breast cancer is constantly expanding and can be accomplished by surgery, radiotherapy, chemotherapy, biological agents and hormone therapy [5]. (bvsalud.org)
HORMONES1
Agents that interfere with male hormones or with hormonal feedback (e.g., testosterone, luteinizing hormone [LH]) may also affect production of healthy sperm, thus affecting fertility [Osorio and Windham 2004]. (cdc.gov)
Estrogen3
We retrospectively reviewed patients' medical records for demographic, disease, hormonal therapy, and estrogen receptor and progesterone receptor expression data. (nih.gov)
A progestin indicated in combination with an estrogen for oral combined hormonal contraceptive therapy. (drugbank.com)
A selective estrogen receptor modulator used as a non-hormonal, non-steroidal oral contraceptive. (drugbank.com)
Therapy7
We searched departmental databases for patients with histologically-confirmed, evaluable, recurrent low-grade serous ovarian or peritoneal carcinoma who received hormonal therapy at our institution between 1989 and 2009. (nih.gov)
We used the Response Evaluation Criteria in Solid Tumors version 1.1 to determine patients' responses to hormonal therapy. (nih.gov)
Because patients could have received more than one evaluable hormonal therapy regimen, we chose to define the outcome metric as "patient-regimens. (nih.gov)
Only patients without visceral crisis and with at least one previous hormonal therapy were considered eligible. (usp.br)
A synthetic hormone used for androgen replacement therapy and as an hormonal antineoplastic agent ( ANTINEOPLASTIC AGENTS, HORMONAL ). (nih.gov)
Nolvadex is an antineoplastic agent used for oral therapy of early breast cancer in men and women. (happyfamilymedstore.com)
Duration of the antineoplastic therapy with Nolvadex can be up to five years. (happyfamilymedstore.com)
Carcinoma2
To determine whether hormonal therapies have efficacy in patients with recurrent low-grade serous carcinoma of the ovary or peritoneum. (nih.gov)
Hormonal therapies have moderate anti-tumor activity in patients with recurrent low-grade serous carcinoma of the ovary or peritoneum. (nih.gov)
Anticancer4
Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents. (wakehealth.edu)
Using fluorescent post-labeling to probe the subcellular localization of DNA-targeted platinum anticancer agents. (wakehealth.edu)
Synthesis, aqueous reactivity, and biological evaluation of carboxylic acid ester-functionalized platinum-acridine hybrid anticancer agents. (wakehealth.edu)
Skip the forgotten dose of this hormonal anticancer medicine if it is almost time for the next tablet. (happyfamilymedstore.com)
Contraception2
Investigated for use/treatment in contraception and male hormonal deficiencies/abnormalities. (drugbank.com)
A vaginal spermicide used for the non-hormonal contraception in conjunction with other modes of contraception. (drugbank.com)
Inhibitors1
Losartan may be administered with other antihypertensive agents (e.g. diuretics, calcium channel blockers, alpha- or beta-blockers, and centrally acting agents) as well as with insulin and other commonly used hypoglycaemic agents (e.g. sulfonylureas, glitazones and glucosidase inhibitors). (stellapharm.com)
Patients1
Patients received 89 separate hormonal patient-regimens, which produced an overall response rate of 9% (6 complete responses and 2 partial responses). (nih.gov)
Abnormalities1
Pethidine, piroxicam, Increased plasma concentrations of norpethidine, propoxyphene piroxicam and propoxyphene, thereby, increasing the risk of serious respiratory depression or haematologic abnormalities, or other serious adverse effects from these agents. (who.int)
Tumors1
Antineoplastic agents that are used to treat hormone-sensitive tumors. (bvsalud.org)
Hormone1
A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. (bvsalud.org)
Treatment2
This is an uncontrolled clinical trial with a convenience sample of women in antineoplastic treatment (CHE and TAM) and non-surgical periodontal FMD treatment. (bvsalud.org)
The current antineoplastic treatment modalities have undesirable side effects. (bvsalud.org)
Breast cancer1
This suggests an importance in hormonal signaling in male breast cancer pathogenesis. (elsevierpure.com)
Potent2
A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer. (wakehealth.edu)
Gold(I) analogues of a platinum-acridine antitumor agent are only moderately cytotoxic but show potent activity against Mycobacterium tuberculosis. (wakehealth.edu)
Cancer1
Analysis of the DNA damage produced by a platinum-acridine antitumor agent and its effects in NCI-H460 lung cancer cells. (wakehealth.edu)
Treat1
A progestin that is administered orally to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy. (drugbank.com)
Active2
This agent is not active when given orally. (medscape.com)
Agents that interfere with the menstrual cycle and ovulation, such as hormonally active agents, may affect fertility [Windham and Osorio 2004]. (cdc.gov)